The Supreme Court on Monday asked the Centre to administer drugs for Tuberculosis on a daily basis, instead of once in three days to patients.
The apex court also sought detailed response from the government by January 31 in same regard.
As per the reports, in India, TB kills more adults than any other infectious disease with reported 2.2 lakh deaths in 2014 and one death occurring almost once in 1.5 minutes.
India is the highest TB burden country with World Health Organisation (WHO) statistics for 2011 giving an estimated incidence figure of 2.2 million cases of TB for India out of 9.6 million cases.
The Government of India along with the Revised National TB Control Programme (RNTCP) and the Initiative for Promoting and Affordable Quality TB Tests (IPAQT) is making some headway in combating tuberculosis.
There is also a voluntary organization named Tuberculosis Association of India set up in February, 1939. It is also affiliated to the government India and is working with TB Delhi center.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
